BriaCell Therapeutics Corp. (BCTX)
3.575
0.00 (0.00%)
USD |
NASDAQ |
Sep 08, 16:00
3.54
-0.04
(-0.98%)
After-Hours: 20:00
BriaCell Therapeutics Debt to Equity Ratio : 0.00 for April 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| April 30, 2026 | 0.00 |
| January 31, 2026 | 0.00 |
| October 31, 2025 | 0.00 |
| July 31, 2025 | 0.00 |
| April 30, 2025 | 0.00 |
| January 31, 2025 | 0.00 |
| October 31, 2024 | 0.00 |
| July 31, 2024 | 0.00 |
| April 30, 2024 | 0.00 |
| January 31, 2024 | 0.00 |
| October 31, 2023 | 0.00 |
| July 31, 2023 | 0.00 |
| April 30, 2023 | 0.00 |
| January 31, 2023 | 0.00 |
| October 31, 2022 | 0.00 |
| April 30, 2022 | 0.00 |
| January 31, 2022 | 0.00 |
| October 31, 2021 | 0.00 |
| April 30, 2021 | 0.00 |
| January 31, 2021 | -0.1092 |
| October 31, 2020 | -0.0768 |
| July 31, 2020 | -0.0694 |
| April 30, 2020 | -0.0778 |
| January 31, 2020 | -0.0666 |
| October 31, 2019 | 0.00 |
| Date | Value |
|---|---|
| July 31, 2019 | -0.4682 |
| April 30, 2019 | 0.4841 |
| January 31, 2019 | -0.8128 |
| October 31, 2018 | 2.282 |
| July 31, 2018 | 1.186 |
| April 30, 2018 | 0.4171 |
| January 31, 2018 | 0.00 |
| October 31, 2017 | 0.00 |
| July 31, 2017 | 0.00 |
| April 30, 2017 | 0.00 |
| January 31, 2017 | 0.00 |
| October 31, 2016 | 0.00 |
| July 31, 2016 | 0.00 |
| April 30, 2016 | 0.00 |
| January 31, 2016 | 0.00 |
| October 31, 2015 | 0.00 |
| July 31, 2015 | 0.00 |
| April 30, 2015 | 0.00 |
| January 31, 2015 | 0.00 |
| October 31, 2014 | 0.00 |
| July 31, 2014 | 0.00 |
| April 30, 2014 | 0.00 |
| January 31, 2014 | 0.00 |
| October 31, 2013 | 0.00 |
| July 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Edesa Biotech, Inc. | 0.00 |
| ProMIS Neurosciences, Inc. | 0.00 |
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
| Oncolytics Biotech, Inc. | -0.0726 |
| Sangamo Therapeutics, Inc. | -1.020 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 27.07M |
| Total Liabilities (Quarterly) | 3.662M |
| Shareholders Equity (Quarterly) | 24.06M |
| Current Ratio | 7.072 |